• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ABCA3缺乏症:新生儿呼吸窘迫的一种罕见病因。

ABCA3 Deficiency: an unusual cause of respiratory distress in the newborn.

作者信息

Anandarajan Mugilan, Paulraj Sunil, Tubman Richard

机构信息

Royal Jubilee Maternity Hospital, Belfast HSC Trust Belfast, BT12 6BB, United Kingdom.

出版信息

Ulster Med J. 2009 Jan;78(1):51-2.

PMID:19252731
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2629021/
Abstract

Respiratory Distress Syndrome (RDS) is due to deficiency of surfactant and commonly occurs in preterm babies. We report the first confirmed case in Northern Ireland of ABCA3 transporter deficiency which is a rare but important cause of RDS in term babies.A 38 week gestation female infant developed respiratory distress at four hours of age. Chest radiography was consistent with RDS. The baby required repeated doses of surfactant, each resulting in transient periods of decreased ventilatory requirement and improvement in blood gases, but unfortunately she did not survive.DNA sequencing demonstrated two different mutations in the ABCA3 gene, one inherited from each parent. The baby was therefore a compound heterozygote, and both mutations were thought to be functionally significant.ABCA3 transporter deficiency is a genetic disorder that is increasingly recognized as a cause of RDS in term babies in whom congenital deficiency of surfactant B and abnormalities of surfactant protein C have been excluded. It should be considered in mature babies who develop severe RDS.

摘要

呼吸窘迫综合征(RDS)是由于表面活性剂缺乏引起的,常见于早产儿。我们报告了北爱尔兰首例经证实的ABCA3转运蛋白缺乏病例,这是足月儿RDS的一种罕见但重要的病因。一名孕38周的女婴在出生4小时后出现呼吸窘迫。胸部X线检查结果与RDS相符。该婴儿需要反复使用表面活性剂,每次使用后通气需求短暂下降,血气指标有所改善,但不幸的是,她最终未能存活。DNA测序显示ABCA3基因存在两种不同的突变,分别来自父母双方。因此,该婴儿为复合杂合子,且两种突变均被认为具有功能意义。ABCA3转运蛋白缺乏是一种遗传性疾病,越来越多地被认为是足月儿RDS的病因,此类足月儿已排除表面活性物质B先天性缺乏和表面活性蛋白C异常的情况。对于出现严重RDS的成熟婴儿,应考虑这一病因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5145/2629021/18a37fc6f532/umj7801-051-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5145/2629021/95330a8cab96/umj7801-051-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5145/2629021/18a37fc6f532/umj7801-051-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5145/2629021/95330a8cab96/umj7801-051-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5145/2629021/18a37fc6f532/umj7801-051-f2.jpg

相似文献

1
ABCA3 Deficiency: an unusual cause of respiratory distress in the newborn.ABCA3缺乏症:新生儿呼吸窘迫的一种罕见病因。
Ulster Med J. 2009 Jan;78(1):51-2.
2
Novel ABCA3 mutations as a cause of respiratory distress in a term newborn.新型 ABCA3 突变导致足月新生儿呼吸窘迫。
Gene. 2014 Jan 25;534(2):417-20. doi: 10.1016/j.gene.2013.11.015. Epub 2013 Nov 20.
3
Single ABCA3 mutations increase risk for neonatal respiratory distress syndrome.单一 ABCA3 突变增加新生儿呼吸窘迫综合征风险。
Pediatrics. 2012 Dec;130(6):e1575-82. doi: 10.1542/peds.2012-0918. Epub 2012 Nov 19.
4
Whole exome sequencing identifies a novel variant in ABCA3 in an individual with fatal congenital surfactant protein deficiency.全外显子组测序在一名致命性先天性表面活性剂蛋白缺乏症患者中鉴定出 ABCA3 中的一个新变异。
Turk J Pediatr. 2021;63(4):703-707. doi: 10.24953/turkjped.2021.04.019.
5
Surfactant proteins gene variants in premature newborn infants with severe respiratory distress syndrome.患有严重呼吸窘迫综合征的早产新生儿的表面活性物质蛋白基因变异体
J Perinatol. 2018 Apr;38(4):337-344. doi: 10.1038/s41372-017-0018-2. Epub 2017 Dec 19.
6
A New Gene Mutation c.3445G>A (p.Asp1149Asn) as a Causative Agent of Newborn Lethal Respiratory Distress Syndrome.一个新的基因突变 c.3445G>A(p.Asp1149Asn)是导致新生儿致死性呼吸窘迫综合征的原因。
Medicina (Kaunas). 2019 Jul 19;55(7):389. doi: 10.3390/medicina55070389.
7
The Haplotype TGGAG in the ABCA3 Gene Increases the Risk of Respiratory Distress Syndrome in Preterm Infants in Southern China.ABCA3基因中的单倍型TGGAG增加了中国南方早产儿呼吸窘迫综合征的风险。
Pediatr Neonatol. 2016 Jun;57(3):188-94. doi: 10.1016/j.pedneo.2015.09.002. Epub 2015 Oct 27.
8
Alteration of the pulmonary surfactant system in full-term infants with hereditary ABCA3 deficiency.足月遗传性ABCA3缺乏婴儿肺表面活性物质系统的改变。
Am J Respir Crit Care Med. 2006 Sep 1;174(5):571-80. doi: 10.1164/rccm.200509-1535OC. Epub 2006 May 25.
9
[Pulmonary surfactant protein adenosine triphosphate-binding-cassette-A3 gene composite mutations in infant congenital interstitial lung disease: report of a case and review of literature].[婴儿先天性间质性肺疾病中肺表面活性物质蛋白三磷酸腺苷结合盒式转运体A3基因复合突变:1例报告并文献复习]
Zhonghua Er Ke Za Zhi. 2016 Oct 2;54(10):761-766. doi: 10.3760/cma.j.issn.0578-1310.2016.10.010.
10
New ATP-binding cassette A3 mutation causing surfactant metabolism dysfunction pulmonary type 3.导致3型表面活性剂代谢功能障碍性肺病的新型ATP结合盒转运蛋白A3突变
Pediatr Int. 2015 Oct;57(5):970-4. doi: 10.1111/ped.12673. Epub 2015 Aug 19.

引用本文的文献

1
Novel Compound Heterozygous Mutation of the Gene in a Patient with Neonatal-Onset Interstitial Lung Disease.一名新生儿期起病的间质性肺疾病患者中该基因的新型复合杂合突变
J Clin Med. 2025 May 25;14(11):3704. doi: 10.3390/jcm14113704.
2
Surfactant Deficiency Causing Severe Pneumonia in a Child.表面活性剂缺乏导致儿童严重肺炎
Curr Health Sci J. 2023 Jan-Mar;49(1):134-138. doi: 10.12865/CHSJ.49.01.134. Epub 2023 Mar 31.
3
Verification of immunology-related genetic associations in BPD supports ABCA3 and five other genes.双相情感障碍中免疫相关基因关联的验证支持ABCA3及其他五个基因。

本文引用的文献

1
Population and disease-based prevalence of the common mutations associated with surfactant deficiency.基于人群和疾病的与表面活性剂缺乏相关的常见突变患病率
Pediatr Res. 2008 Jun;63(6):645-9. doi: 10.1203/PDR.0b013e31816fdbeb.
2
Novel mutations in the gene encoding ATP binding cassette protein member A3 (ABCA3) resulting in fatal neonatal lung disease.编码ATP结合盒蛋白成员A3(ABCA3)的基因中的新型突变导致致命的新生儿肺部疾病。
Acta Paediatr. 2007 Feb;96(2):185-90. doi: 10.1111/j.1651-2227.2007.00016.x.
3
Surfactant composition and function in patients with ABCA3 mutations.
Pediatr Res. 2022 Jul;92(1):190-198. doi: 10.1038/s41390-021-01689-y. Epub 2021 Aug 31.
4
Cellular Reprogramming and Immortality: Expression Profiling Reveals Putative Genes Involved in Turritopsis dohrnii's Life Cycle Reversal.细胞重编程与永生:表达谱分析揭示了与塔玛多利虫永生相关的候选基因。
Genome Biol Evol. 2021 Jul 6;13(7). doi: 10.1093/gbe/evab136.
5
Multidrug Resistance in Mammals and Fungi-From MDR to PDR: A Rocky Road from Atomic Structures to Transport Mechanisms.哺乳动物和真菌中的多药耐药性——从 MDR 到 PDR:从原子结构到转运机制的艰难历程。
Int J Mol Sci. 2021 Apr 30;22(9):4806. doi: 10.3390/ijms22094806.
6
The biology of the ABCA3 lipid transporter in lung health and disease.ABCA3脂质转运蛋白在肺部健康与疾病中的生物学特性
Cell Tissue Res. 2017 Mar;367(3):481-493. doi: 10.1007/s00441-016-2554-z. Epub 2016 Dec 26.
7
Interstitial lung disease in two brothers with novel compound heterozygous ABCA3 mutations.两兄弟的间质性肺病与新型复合杂合 ABCA3 突变。
Eur J Pediatr. 2013 Jul;172(7):953-7. doi: 10.1007/s00431-013-1977-8. Epub 2013 Feb 27.
8
Respiratory distress syndrome due to a novel homozygous ABCA3 mutation in a term neonate.一名足月儿因新型纯合ABCA3突变导致的呼吸窘迫综合征。
BMJ Case Rep. 2011 Mar 3;2011:bcr1020103427. doi: 10.1136/bcr.10.2010.3427.
9
Genetic Basis of Children's Interstitial Lung Disease.儿童间质性肺疾病的遗传基础
Pediatr Allergy Immunol Pulmonol. 2010 Mar;23(1):15-24. doi: 10.1089/ped.2009.0024.
10
Surfactant Metabolism Dysfunction and Childhood Interstitial Lung Disease (chILD).表面活性剂代谢功能障碍与儿童间质性肺疾病(chILD)
Ulster Med J. 2009 Jan;78(1):7-9.
ABCA3 突变患者的表面活性剂组成与功能
Pediatr Res. 2006 Jun;59(6):801-5. doi: 10.1203/01.pdr.0000219311.14291.df. Epub 2006 Apr 26.
4
Genetic disorders influencing lung formation and function at birth.影响出生时肺形成和功能的遗传疾病。
Hum Mol Genet. 2004 Oct 1;13 Spec No 2:R207-15. doi: 10.1093/hmg/ddh252.
5
ABCA3 gene mutations in newborns with fatal surfactant deficiency.患有致命性表面活性物质缺乏症的新生儿中的ABCA3基因突变。
N Engl J Med. 2004 Mar 25;350(13):1296-303. doi: 10.1056/NEJMoa032178.